WASHINGTON, June 24 (Reuters) - U.S. lawmakers criticized the Food and Drug
Administration on Tuesday for not aggressively policing the import of
prescription drugs and stopping the entry of illegal knock-offs and counterfeit
medicines.
Members
of the House Oversight and Investigations Subcommittee said the FDA's
enforcement had been stagnant since Congress held a similar hearing in 2001.
They
cited the FDA's actions last month in letting through unauthorized versions of
the anti-impotence drug Viagra, after the shipment was detained by customs
officials.
"Given
the exponential increase in the volume of drugs being imported into the
U.S., FDA's current approach must be substantially altered," said
subcommittee Chairman Rep. Jim Greenwood, a Pennsylvania Republican.
But some
lawmakers said the entry of cheaper imports would be impossible to stop while
U.S. drug prices remained so high.
"We have
done nothing to control the price of drugs," said Illinois Democrat Rep. Jan
Schakowsky said. "Is it any wonder that people are turning to other places to
get it?"
The U.S.
Senate backed a measure last week that would allow experimentation with imports
of U.S.-approved pharmaceuticals from Canada but it would require
safety certification from U.S. officials who have failed to endorse previous
import plans.
About 60
million pharmaceuticals enter the United States through mail
annually, an increase of 1,000 percent since 2001, Greenwood said.
Mail
importation is currently allowed for serious conditions where a drug is not
available in the United States.
But a
wide range of common prescription drugs can be bought outside the
United States and online, including cholesterol-lowering drug Lipitor
and Procrit, an anemia treatment given to cancer and HIV patients. Pfizer Inc.
PFE.N markets Lipitor and Johnson & Johnson
JNJ.N markets Procrit.
The
FDA's critics say it has turned a blind eye to imported pharmaceuticals that
can be as much as 90 percent cheaper than those bought at home but may turn out
to be counterfeit and offer no health benefits.
In some
instances, foreign companies sell drugs that have expired dates, have an
incorrect dose or have no medicinal value, rendering them as effective as sugar
pills, said FDA Associate Commissioner William Hubbard.
Since
the Miami incident involving unapproved Viagra, another Pfizer
drug, the agency has launched an internal investigation and is training its
investigators to identify imported drugs, FDA Associate Commissioner John
Taylor testified.
|